Neuralstem, Inc. Human Resources Contracts & Agreements
29 Contracts & Agreements
- Bonus & Incentive Agreements (11 contracts)
- Compensation Agreements (1)
- Consulting Agreements (1)
- Employment Agreements (13)
- Separation Agreements (3)
- Form of Employment Agreement with J.D. Finley, dated September 25, 2024 (Filed With SEC on September 27, 2024)
- Form of Employment Agreement with Mitchell Jones, dated September 5, 2023 (Filed With SEC on September 11, 2023)
- Palisade Bio, Inc. 2021 Inducement Incentive Plan, as Amended August 7, 2023 (Filed With SEC on August 10, 2023)
- Palisade 2021 Equity Incentive Plan, as amended (Filed With SEC on June 9, 2023)
- Separation Agreement and Release with former Chief Executive Officer (Filed With SEC on October 14, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on March 17, 2022)
- Palisade Bio, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on November 23, 2021)
- Form of Non-Employee Director Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)
- Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)
- Palisade Bio, Inc. 2021 Inducement Incentive Plan (Filed With SEC on November 23, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on August 23, 2021)
- Form of Separation Agreement (Filed With SEC on March 18, 2021)
- Leading BioSciences, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement and... (Filed With SEC on December 23, 2020)
- Executive Employment Agreement, by and between Leading BioSciences, Inc. and JD Finley, dated December 16, 2020 (Filed With SEC on December 23, 2020)
- Executive Employment Agreement, by and between Leading BioSciences, Inc. and Thomas Hallam, Ph.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)
- Executive Employment Agreement, by and between Leading BioSciences, Inc. and Michael Dawson, M.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)
- Employment Agreement with Matthew Kalnik, PhD (Filed With SEC on April 2, 2020)
- Employment Agreement with Dane Saglio (Filed With SEC on April 2, 2020)
- Amendment to Employment Agreement with Kenneth Carter effective April 1,2020 (Filed With SEC on March 27, 2020)
- Form of Restricted Stock Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Stock Option Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Restricted Stock Unit from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
- Kenneth Carter Employment Agreement (Filed With SEC on December 18, 2018)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 4, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 19, 2016)
- EMPLOYMENT AGREEMENT AMENDMENT (Filed With SEC on March 2, 2015)
- EMPLOYMENT AGREEMENT AMENDMENT (Filed With SEC on September 18, 2014)
- EMPLOYMENT AGREEMENT RENEWAL AND AMENDMENT (Filed With SEC on July 27, 2012)
- MANAGEMENT CONSULTING AGREEMENT (Filed With SEC on March 16, 2011)
